1. Introduction
1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:
4. Europe Drug Delivery Systems Market Landscape
4.1 Market Overview
4.2 Porter's Five Forces Analysis
- 4.2.1 Bargaining Power of Suppliers
- 4.2.2 Bargaining Power of Buyers
- 4.2.3 Threat of New Entrants
- 4.2.4 Competitive Rivalry
- 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
- 4.3.1 Raw Material Suppliers
- 4.3.2 Manufacturers
- 4.3.3 Distributors/Suppliers
- 4.3.4 End Users
5. Europe Drug Delivery Systems Market – Key Market Dynamics
5.1 Growth Drivers
- 5.1.1 Growing demand for targeted drug delivery systems
- 5.1.2 Advancements in drug delivery technologies for chronic diseases
5.2 Market Opportunities
- 5.2.1 Advancements in drug delivery technologies creating opportunities for targeted and efficient drug delivery systems
- 5.2.2 Rising demand for personalized drug delivery driving market growth
5.3 Future Trends
- 5.3.1 Demand for non-invasive drug delivery systems
- 5.3.2 Advancements in controlled-release and personalized drug delivery solutions
5.4 Impact of Drivers and Restraints
6. Europe Drug Delivery Systems Market Regional Analysis
6.1 Europe Drug Delivery Systems Market Overview
6.2 Europe Drug Delivery Systems Market Revenue 2016-2027 (US$ Million)
6.3 Europe Drug Delivery Systems Market Forecast Analysis
7. Europe Drug Delivery Systems Market Analysis – by Route of Administration
7.1 Transmucosal
- 7.1.1 Overview
- 7.1.2 Transmucosal: Europe Drug Delivery Systems Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Oral
- 7.2.1 Overview
- 7.2.2 Oral: Europe Drug Delivery Systems Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Injectable
- 7.3.1 Overview
- 7.3.2 Injectable: Europe Drug Delivery Systems Market – Revenue and Forecast to 2031 (US$ Million)
7.4 Topical
- 7.4.1 Overview
- 7.4.2 Topical: Europe Drug Delivery Systems Market – Revenue and Forecast to 2031 (US$ Million)
7.5 Implantable
- 7.5.1 Overview
- 7.5.2 Implantable: Europe Drug Delivery Systems Market – Revenue and Forecast to 2031 (US$ Million)
7.6 Ocular
- 7.6.1 Overview
- 7.6.2 Ocular: Europe Drug Delivery Systems Market – Revenue and Forecast to 2031 (US$ Million)
8. Europe Drug Delivery Systems Market Analysis – by Distribution Channel
8.1 Hospital Pharmacies
- 8.1.1 Overview
- 8.1.2 Hospital Pharmacies: Europe Drug Delivery Systems Market – Revenue and Forecast to 2027 (US$ Million)
8.2 Retail Pharmacies
- 8.2.1 Overview
- 8.2.2 Retail Pharmacies: Europe Drug Delivery Systems Market – Revenue and Forecast to 2027 (US$ Million)
8.3 Online Pharmacies
- 8.3.1 Overview
- 8.3.2 Online Pharmacies: Europe Drug Delivery Systems Market – Revenue and Forecast to 2027 (US$ Million)
9. Europe Drug Delivery Systems Market Analysis – by Application
9.1 Home Care Settings
- 9.1.1 Overview
- 9.1.2 Online Pharmacies: Europe Drug Delivery Systems Market – Revenue and Forecast to 2027 (US$ Million)
9.2 Hospitals & Clinics
- 9.2.1 Overview
- 9.2.2 Online Pharmacies: Europe Drug Delivery Systems Market – Revenue and Forecast to 2027 (US$ Million)
10. Europe Drug Delivery Systems Market – Europe Analysis
10.1 Europe
- 10.1.1 Europe Drug Delivery Systems Market Breakdown, by Key
Country, 2019 and 2027 (%)
- 10.1.1.1 Europe Drug Delivery Systems Market – Revenue and
Forecast Analysis – by Country
- 10.1.1.1 UK:
Europe Drug Delivery Systems Market – Revenue and Forecast to 2027 (US$ Million)
- 10.1.1.1.1 UK: Europe Drug Delivery Systems Market Breakdown, by Route of Administration
- 10.1.1.1.2 UK: Europe Drug Delivery Systems Market Breakdown, by Distribution Channel
- 10.1.1.1.3 UK: Europe Drug Delivery Systems Market Breakdown, by Application
- 10.1.1.2 Germany:
Europe Drug Delivery Systems Market – Revenue and Forecast to 2027 (US$ Million)
- 10.1.1.2.1 Germany: Europe Drug Delivery Systems Market Breakdown, by Route of Administration
- 10.1.1.2.2 Germany: Europe Drug Delivery Systems Market Breakdown, by Distribution Channel
- 10.1.1.2.3 Germany: Europe Drug Delivery Systems Market Breakdown, by Application
- 10.1.1.3 France:
Europe Drug Delivery Systems Market – Revenue and Forecast to 2027 (US$ Million)
- 10.1.1.3.1 France: Europe Drug Delivery Systems Market Breakdown, by Route of Administration
- 10.1.1.3.2 France: Europe Drug Delivery Systems Market Breakdown, by Distribution Channel
- 10.1.1.3.3 France: Europe Drug Delivery Systems Market Breakdown, by Application
- 10.1.1.4 Russia:
Europe Drug Delivery Systems Market – Revenue and Forecast to 2027 (US$ Million)
- 10.1.1.4.1 Russia: Europe Drug Delivery Systems Market Breakdown, by Route of Administration
- 10.1.1.4.2 Russia: Europe Drug Delivery Systems Market Breakdown, by Distribution Channel
- 10.1.1.4.3 Russia: Europe Drug Delivery Systems Market Breakdown, by Application
- 10.1.1.5 Italy:
Europe Drug Delivery Systems Market – Revenue and Forecast to 2027 (US$ Million)
- 10.1.1.5.1 Italy: Europe Drug Delivery Systems Market Breakdown, by Route of Administration
- 10.1.1.5.2 Italy: Europe Drug Delivery Systems Market Breakdown, by Distribution Channel
- 10.1.1.5.3 Italy: Europe Drug Delivery Systems Market Breakdown, by Application
- 10.1.1.6 Rest of Europe:
Europe Drug Delivery Systems Market – Revenue and Forecast to 2027 (US$ Million)
- 10.1.1.6.1 Rest of Europe: Europe Drug Delivery Systems Market Breakdown, by Route of Administration
- 10.1.1.6.2 Rest of Europe: Europe Drug Delivery Systems Market Breakdown, by Distribution Channel
- 10.1.1.6.3 Rest of Europe: Europe Drug Delivery Systems Market Breakdown, by Application
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. Europe Drug Delivery Systems Market Industry Landscape
12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments
13. Company Profiles
13.1 BD
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Novo Nordisk A/S
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 3M
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Boston Scientific Corporation
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Bausch Health Companies Inc.
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Baxter International, Inc.
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Boehringer Ingelheim
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Novartis AG
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 GlaxoSmithKline plc.
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 Johnson & Johnson Services, Inc.
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments
14. Appendix
14.1 About Business Market Insights